https://endpts.com/novo-nordisk-to-restrict-starter-dose-supply-for-weight-loss-drug-wegovy/
0
0
5/4/23 at 3:27pm
Organization
Endpoints News
Author
Nicole DeFeudis
Faced with “all-time high levels” of new patients starting Novo Nordisk’s GLP-1 products, the company is temporarily restricting its supply of lower Wegovy dose strengths to “safeguard continuity of care,” according to EVP of North America operations Doug Lan…
Create an account
or login to join the discussion